Peptide CDMOs

Contract Development and Manufacturing Organizations (CDMOs) specializing in peptide synthesis from clinical batches to commercial-scale production. Ideal for pharmaceutical and biotech enterprises requiring GMP-compliant facilities and regulatory support. CDMOs typically hold FDA and EMA inspected facilities covering solid-phase synthesis, purification, lyophilization, and analytical method development. Major peptide CDMOs serve both innovator drug developers and generic API customers across metabolic disease, oncology, and endocrinology therapeutic areas. Bachem, PolyPeptide, Lonza, CordenPharma, and WuXi AppTec represent the largest global CDMO capacity for peptide active pharmaceutical ingredients. Showing 115 listed suppliers.

Our directory lists peptide cdmos operating across Global, Europe, North America, Asia, serving pharmaceutical development, research institutions, and commercial buyers. Browse individual profiles below for detailed information on manufacturing capabilities, certifications, minimum order quantities, product catalogs, and quality documentation.

Directory listing last reviewed July 2026.